- Report
- May 2024
- 185 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- May 2024
- 180 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- November 2023
- 122 Pages
Asia Pacific
From €3550EUR$4,000USD£3,067GBP
- Report
- May 2024
- 200 Pages
Global
From €3683EUR$4,150USD£3,182GBP
- Report
- May 2024
- 200 Pages
Global
From €3683EUR$4,150USD£3,182GBP
- Report
- March 2024
- 200 Pages
Global
From €3683EUR$4,150USD£3,182GBP
- Report
- July 2024
- 80 Pages
Japan
From €3106EUR$3,500USD£2,684GBP
- Report
- May 2024
- 185 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- February 2024
- 180 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- February 2024
- 184 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- November 2023
- 188 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- June 2023
- 110 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- May 2024
- 100 Pages
Africa, Middle East
From €3062EUR$3,450USD£2,645GBP
- Report
- July 2024
- 130 Pages
Global
From €4216EUR$4,750USD£3,642GBP
- Report
- July 2024
- 120 Pages
Global
From €4216EUR$4,750USD£3,642GBP
- Report
- July 2024
- 170 Pages
Global
From €4216EUR$4,750USD£3,642GBP
- Report
- July 2024
- 120 Pages
Global
From €4216EUR$4,750USD£3,642GBP
- Report
- July 2024
- 120 Pages
Global
From €4216EUR$4,750USD£3,642GBP
- Report
- April 2023
- 117 Pages
Global
From €4216EUR$4,750USD£3,642GBP
- Report
- February 2024
- 150 Pages
Global
From €4216EUR$4,750USD£3,642GBP

Process Development in biotechnology is the process of designing, optimizing, and validating manufacturing processes for biopharmaceuticals. It involves the development of processes for the production of biopharmaceuticals, such as monoclonal antibodies, recombinant proteins, and vaccines. The process development process includes the development of analytical methods, process characterization, process optimization, and process validation. It also involves the development of process control strategies, such as process monitoring and process control systems.
Process development is a critical step in the development of biopharmaceuticals, as it ensures that the product is safe, effective, and of high quality. It is also important for the efficient and cost-effective production of biopharmaceuticals.
Companies in the Process Development market include Merck, Pfizer, Novartis, Amgen, and Genentech. Show Less Read more